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Abstract
Background. Pain is strongly associated with sig-
nificant personal and societal costs. A crucial
element of any initiative on pain must focus on elimi-
nating pain care disparities that are pervasive
throughout the United States health care settings.
Objectives. This report focuses on macro-level
factors related to pain care disparities in the United
States that may be amenable to policy interventions.
Methods. We identify concrete opportunities for
achieving equity in pain care, especially those occa-
sioned by recent legislative changes in the United
States health care system. An aggressive policy,
advocacy, and research agenda is synthesized in
five domains: 1) structural/system; 2) policy and
advocacy; 3) workforce; 4) provider; and 5)
research.
Results. Inequities in pain care remain an important
and neglected health policy concern. Many direct
and indirect provisions within the Affordable Care
Act (ACA) and other national initiatives that leverage
on ACA offer opportunities to achieve equity in pain
care. These include changes in insurance, in public,
provider, and legislative education, in primary care
and pain specialist training, improving workforce
diversity, achieving uniformity in race/ethnicity data
collection, emphasizing patient-centered outcomes
research, and encouraging focus on pain care dis-
parities within the comparative effectiveness
research paradigm.
Conclusions. Recent national legislative initiatives
within ACA are expected to generate multilevel
efforts that will impact the flow of funding to address
the pervasive issue of disparities. It is an opportune
time for the pain community to take a lead in imple-
menting a concerted agenda on pain care disparities
in order to leverage these national initiatives.
Key Words. Pain; Disparities–Ethnic; Disparities–
Racial; Pain Management; Pain Treatment; Policy;
Advocacy; Legislation; Ethnic Disparities; Opioids;
Analgesics; United States
Introduction
In 2000, Congress passed the Minority Health and Health
Disparities Research and Education Act (P.L. 106-525)
establishing National Institutes of Health’s (NIH) National
Center on Minority Health and Health Disparities (NCMHD;
recently renamed as National Institute on Minority Health
and Health Disparities, NIMHD) and charged the center
with administering special grant programs focusing on
disparities, coordinating minority health disparities
research across NIH Institutes, and spearheading the
development of an NIH-wide Strategic Plan on health
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disparities. This effort resulted in unprecedented develop-
ments, including 27 NIH Institutes and Centers developing
individual strategic agendas to eliminate health disparities.
Some of these agendas recognized the importance of
disparities in pain care.
At about the same time, the 106th United States Con-
gress passed Title VI, Section 1603, of H.R. 3244 declar-
ing the era starting 2000 as the “Decade of Pain Control
and Research” [1,2]. Subsequent high-profile pain initia-
tives included the Veterans Pain Care Act of 2008 (H.R.
6122), Military Pain Care Act of 2008 (H.R. 5465), and
the National Pain Care Policy Act of 2009 (H.R. 756/
S.660), provisions from which were included in the
Affordable Care Act (ACA) signed in to law by President
Obama in March 2010 [3]. These high-profile initiatives
placed pain on the national agenda as a major public
health problem—one with real social and fiscal conse-
quences. The problem of pain cuts across disease enti-
ties and treatment settings. According to recent
estimates, 116 million American adults suffer from
chronic pain; pain remains the principal reason for which
people seek medical care [4,5]. Chronic pain is strongly
associated with societal costs measured in terms of dis-
ability, poor quality of life, relational problems, lost income
and productivity, and higher health care utilization includ-
ing longer hospital stay, emergency room visits, and
unplanned clinic visits. The burden to Americans are
reflected in an enormous annual expenditure that ranges
$560–$635 billion in direct and indirect costs [5]—a
marked increase from the previously estimated cost of
$100 billion [6] and an estimated cost of employees’
chronic pain to businesses of $61 billion [7]. Despite
chronic pain’s concerning socioeconomic impact, many
aspects of pain care, training, and research remain
grossly under-resourced [8,9]. Only less than 1% of the
NIH research budget is invested in pain and symptom
management research [10] (Box 1).
A crucial element of any initiative on pain must focus on
improving pain care for racial and ethnic minorities, poor,
and other vulnerable populations. Significant racial and
ethnic disparities exist throughout health care settings
reflecting in both inequitable treatment and disparate pain
care outcomes [11–15]. Almost a decade ago, the Insti-
tute of Medicine (IOM) report [16], “Unequal Treatment:
Confronting Racial and Ethnic Disparities in Health Care,”
compiled data on racial and ethnic disparities across
disease conditions (including pain) and concluded that:
“Racial and ethnic disparities in healthcare . . . are consis-
tent across a range of medical conditions and healthcare
services, are associated with worse health outcomes, and
occur independently of insurance status, income and edu-
cation, among other factors that influence accesses to
healthcare” (p. 79). Subsequently, the 2006 IOM report,
Examining the Health Disparities Research Plan of the
National Institutes of Health: Unfinished Business [17],
found that while NIH ranks health disparities third among
its top five strategic priorities, important gaps still exist in
areas of planning, coordination, comprehensiveness, and
funding.
Recent national initiatives such as National Partnership for
Action to End Health Disparities [18] leverage provisions
within the ACA (including elevation of NCMHD to an Insti-
tute status under Section 10334). Such initiatives are
expected to generate multilevel efforts that will impact the
flow of funding to address the pervasive issue of dispari-
ties. Nevertheless, health care disparities are mammoth
problems that reach beyond broad policy and legislative
efforts that are underway. If the latter efforts are to impact
disparities in a meaningful way, it is important that the
scientific community also takes a lead in developing
a concerted agenda on health disparities in order to
leverage these national initiatives.
This special report situates pain treatment disparities in
the context of their impact on patients, health systems,
and outcomes. We highlight opportunities for achieving
equity in pain care, especially those occasioned by recent
legislative changes in the United States health care
system. This work is informed by a series of efforts by the
pain community. In particular, Green and colleagues in
2003 published an influential article in Pain Medicine, “The
unequal burden of pain: Confronting racial and ethnic
Box 1 Pain and disparities facts in perspective
Chronic pain affects 116 million American adults [5];
pain is the number one reason for which people seek
medical care.
Pain strongly correlates with disability, poor quality of
life, relational problems, lost income and productivity,
and higher health care utilization.
The estimated expenditure in direct and indirect cost of
pain ranges $560–$635 billion annually [5].
In contrast, less than 1% of the National Institutes of
Health (NIH) research budget is devoted to pain and
symptom management research [10].
No research has quantified the costs of pain treatment
disparities but they are expected to be high given the
pervasiveness of pain care disparities across health
care settings [11–15,19–21].
The direct and indirect cost of overall health disparities,
between 2003 and 2006, was estimated to be $1.24
trillion [73].
In contrast, the total NCMHD budget for FY 2011
devoted to health disparities research, capacity-
building, and outreach/dissemination is only $219
million [154].
The total NIH budget across all NIH Institutes devoted
to health disparities research is approximately $2.8
billion [74].
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disparities in pain” [14]. This critical review, generated by
the members of the American Pain Society’s Special Inter-
est Group on Pain Disparities, documented widespread
racial and ethnic disparities in pain assessment and treat-
ment across settings for all types of pain—acute, cancer,
and chronic nonmalignant. The results underscored the
complex sources of these disparities, citing contributing
factors at the patient, health care provider, and system
levels. The authors recommended that “a comprehensive
pain research agenda is necessary to address pain dis-
parities among racial and ethnic minorities” (p. 277). This
paper was followed by a special supplement in Pain Medi-
cine, co-edited by Carmen Green and Raymond Tait,
devoted to pain care disparities (2005, volume 6, issue 1).
The current work was part of a larger effort to synthesize
issues around pain care disparities, which included a con-
ference held in Philadelphia in October 2006, titled,
“Racial/Ethnic Disparities in Pain Treatment: Converting
Research to Policy.” The conference was organized under
the auspices of the Center for Health Equity Promotion at
the Philadelphia Veterans Affair (VA) Medical Center and
supported by an unrestricted educational grant. Invitees
included key scientific and clinical investigators involved
in the conduct of pain disparities research, leaders
from patient advocacy groups, bioethicists, and health
policy makers. Subsequently, many authors have synthe-
sized issues pertaining to pain treatment disparities
[11,13,15,19–21].
This paper focuses on macro-level factors related to
pain treatment disparities that may be amenable to policy
interventions. We have organized this paper in five
domains: 1) structural/system; 2) policy and advocacy; 3)
workforce; 4) provider; and 5) research (see Tables 1, 5, 7,
8, and 9, respectively). In each domain, issues related to
pain disparities are summarized and then followed by
corresponding recommendations.
A. Structural/System Factors: Summary of Issues
A1. Poverty and Racial/Ethnic Minority Status are
Tied to Both the Experience of Pain and the
Treatment of Pain in the United States
Poverty and racial and ethnic minority status are tied to
both the experience of pain and the treatment of pain in
Table 1 Structural/system factors: Recommendations for change
# Issues/Perspectives Recommendations
A1 Poverty and racial/ethnic
minority status are tied to
both the experience of pain
and the treatment of pain in
the United States.
a. Federal agencies, such as the Centers for Disease Control, should invest in
broad public education and primary prevention programs to target pain care
disparities.
b. ACA Health Insurance Reform and federal minimum standards for Medicaid
income eligibility have implications for improving access. Pain community
should pay close attention to how access to pain care can be improved within
these broad reforms.
A2 Lack of insurance and
underinsurance are the
major structural barriers to
achieving equity in pain
care among poor and
minorities.
a. Address meaningful access to effective pain care in health insurance reform.
b. Understand how corporate risk management strategies, preferred medication
lists, or other third-party payer systems widen racial/ethnic disparities pain
treatment.
c. Providers/health care entities should develop an easy-to-navigate system to
assist use of patient assistance programs for obtaining medications.
A3 Individuals living in regions
of poverty or racially
segregated neighborhoods
lack geographic access to
pharmacies that carry
opioids needed to relieve
moderate to severe pain.
a. Establish a uniform policy of opioid availability such that risk management
programs are geared to improving training, security, and transparency.
b. Establish regulatory systems that oversee the acquisition, dispensing, and
monitoring of opioids in ways that increase access without fear of regulatory
action.
A4 Language barriers widen
pain care disparities for
racial and ethnic groups
with limited English
proficiency (LEP).
a. Uniform reimbursement models are needed for language and translation
services that improve equity in access.
b. Accreditation organizations must promote standards for the effective use of
language and interpreter services; providers may not be trained to use
interpreters effectively for optimal communication, even when good ones are
available.
c. Accreditation organizations must emphasize training specific to pain care,
including defining the components of “meaningful language access” in the
settings of pain treatment. These training programs should also focus
specifically on processes that generate disparities.
ACA = Affordable Care Act.
7
Agenda to Eliminate Disparities in Pain
the United States. Poor and minority patients suffer more
severe pain [22–24], pain-related disabilities, and physical
impairments than nonminority patients [23,25]. They are
more likely to demonstrate risk factors that mediate racial
and ethnic disparities in the experience of pain and in its
treatment, including chronic psychiatric and medical
comorbidities, higher levels of psychological distress,
lower educational levels, and insurance types (such as
Medicaid) [23,24,26,27]. Racial and ethnic minorities, indi-
viduals with low socioeconomic status (SES), and those
with limited English proficiency (LEP) are also likely to
perform potentially harmful physical work, increasing their
risks for disabilities related to occupational injuries [28,29].
Minorities, low SES, and uninsured patients are more likely
to wait to receive care when sick, encounter delays in
care, experience poorly coordinated care, experience
avoidable hospitalizations, and demonstrate worse treat-
ment outcomes [30]. They are also less likely to have
accessible source of primary care [30], a setting where the
majority of chronic pain is managed in the United States
[31].
Specific to treatment, racial and ethnic minorities are less
likely (than White people) to have their pain assessed
[32,33] and are less likely to receive analgesia in virtually all
health care settings in the United States, including emer-
gency departments (EDs) [34–38], inpatient and postop-
erative pain settings [39–42] and outpatient, community,
and nursing home settings [33,43–45]. They are also less
likely than White people to receive opioids [36,37,46,47]
and selective nonsteroidal anti-inflammatory drugs
(NSAIDs) for arthritis pain [48]. Furthermore, minorities are
more likely to experience a step-down in analgesia at
discharge from a hospital or emergency room [36,46,49]
and encounter longer wait times in receiving analgesics
[50,51].
A2. Lack of Insurance and Underinsurance are
Major Structural Barriers to Achieving Equity in Pain
Care Among Poor and Minorities
Lack of health insurance is the one of the major structural
barriers to access to pain care in the United States. While
existing laws such as Emergency Medical Treatment and
Active Labor Act (EMTALA) allow access to EDs for
screening and stabilization of emergent medical condi-
tions [52], EDs are poor substitutes for primary care pro-
viders (PCPs) for individuals suffering from chronic
persistent pain who need comprehensive sets of services
to improve outcomes. Moreover, poverty, minority status,
and insurance status overlap significantly in the United
States. In 2010, 46.7 million Americans (15.4%) were
uninsured and 59.1 million (19.5%) were in and out of
insurance coverage for at least part of the previous year
[53]. Of the uninsured, over one-third had less than a high
school education, and over half were poor or near-poor
(100–200% of poverty threshold) [53]. Of those who were
in and out of insurance coverage, minorities represented
about one-quarter of all individuals who were so affected.
Given these data, it is not surprising that minorities report
Table 2 Pain disparities agenda is not explicitly or consistently identified in the advocacy mission of the
prominent pain advocacy groups in the United States
Organization Mission Statement
American Pain
Foundation
The American Pain Foundation educates, supports, and advocates for people affected by
pain . . . APF stands up with people living with pain, caregivers, health care providers
and allied organizations, working together to dismantle the barriers that impede access
to quality pain care for all.
American Pain Society
(Advocacy arm)
The American Pain Society has identified a broad agenda of pain issues and advocates in
numerous arenas to improve the care of patients with pain. The society’s goals are to
advance the treatment of people in pain by ensuring access to treatment, removing
regulatory barriers, and educating practitioners and policy makers in all settings about
advances and economics of effective pain treatment.
American Academy of
Pain Management
The American Academy of Pain Management advances the field of pain management
using an integrative model of patient-centered care, by providing evidence-based
education for pain practitioners, as well as credentialing and advocacy for its members.
American Academy of
Pain Medicine (AAPM)
(Advocacy arm)
AAPM supports pain patients and pain medicine clinicians by advocating for a balanced
approach to safe and effective treatment of pain. The academy recognizes the need for
policies that support effective control of drug abuse without harming the appropriate
treatment of pain and works with members and other pain societies to establish
programs and to educate public along those lines.
American Society for
Pain Management
Nursing
The American Society for Pain Management Nursing advances and promotes optimal
nursing care for people affected by pain by promoting best nursing practice. This is
accomplished through education, standards, advocacy, and research.
The Mayday Fund The Mayday Fund is dedicated to alleviating the incidence, degree, and consequence of
human physical pain.
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frequent emergency room utilization for the management
of chronic pain [54], often at the expense of continuity of
care.
The insurance industry’s focus on cost-containment and
profitability extends the barrier of underinsurance to those
with any insurance through tactics that result in failure to
reimburse services and medications despite evidence-
base for clinical or cost-efficiency [55]; a good example is
“carving out” of important services from interdisciplinary
pain treatment programs [55,56]. Thus, insurance com-
panies define the type and quality of pain care individuals
receive in the United States. While all insurance-funded
care in the United States is managed care, it is well-
documented that poor and minority patients are more
likely to be in those managed care environments that
impose stringent limits on referrals and out-of-network
access [57]. Such systems directly impact access to spe-
cialist pain services, as studies have found that more
out-of-network benefits allow greater access to pain spe-
cialists and the interdisciplinary programs that are effective
in chronic pain [58]. While patients in restrictive managed
care plans can self-refer, those plans impose financial
penalties for self-referrals, a practice that disproportion-
ately affects poor and underinsured patients [58].
Many direct and indirect provisions in the ACA have impli-
cations for improving access and quality of care for poor,
uninsured, and underinsured. These include the Health
Insurance Reform provisions, as well as establishing
uniform federal criteria for Medicaid income eligibility,
expanding it to 133% of the federal poverty line (Section
2001). The pain community should pay close attention to
how access to appropriate and effective pain care can be
improved for the underserved populations within these
broader reforms.
A3. Individuals Living in Regions of Poverty or
Racially Segregated Neighborhoods Lack
Geographic Access to Pharmacies that Carry
Opioids Needed to Relieve Moderate to Severe Pain
Minorities and poor patients in the United States live pre-
dominantly in geographic areas that constrain their access
Table 3 Specific Affordable Care Act provisions relevant to pain disparities agenda [3]
Section Provision Description
Sec. 4305. Advancing
Research and
Treatment for Pain
Care Management
Institute of Medicine
(IOM) Conference on
Pain to:
• Increase recognition of pain as public health problem in the United
States
• Evaluate assessment, diagnosis, treatment of pain
• Support disparities research in pain care
• Plan to reduce barriers and improve education, research, clinical
care
• Train providers in pain care, including culturally and linguistically
appropriate services
Sec. 409J. Pain
Research
Pain Consortium and
Interagency Pain
Research
Coordinating
Committee
• Pain Consortium to expand program of research examining causes
and treatments for pain and submit recommendations for
appropriate research initiatives at least annually
• Interagency Pain Research Coordinating Committee to coordinate
all efforts within HHS and other Federal agencies related to pain
research. The coordinating committee will:
• Develop a summary of pain care research supported or conducted
by Federal agencies
• Identify research gaps
• Generate recommendations to ensure no overlap in effort occurs
• Make recommendations on dissemination as well as on expanding
partnerships between public and private entities
Sec. 759. Program
for education and
training in pain care
Award grants,
cooperative
agreements, and
contracts to health
profession schools,
hospices, and other
public and private
entities to develop
education and
training programs in
pain care.
Program will include education on:
• Recognized means for assessing, diagnosing, treating, and
managing pain and related signs and symptoms
• Laws, regulations, rules, policies on controlled substances, and
how misconceptions and concerns create barriers
• Interdisciplinary approaches to pain care, including specialized
centers
• Cultural, linguistic, literacy, geographic, and other barriers in
underserved populations
• Recent findings, developments, improvements in the provision of
pain care
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to needed health care, regardless of insurance status.
Regional surveys of pharmacies in the United States have
found stark differences in opioid availability by the SES
and racial configurations of neighborhoods [59,60]. For
instance, Green et al. investigated the availability of
opioids in randomly selected pharmacies across the state
of Michigan and found that pharmacies in predominantly
white zip codes (>70% White people) were 54 times more
likely to have sufficient opioid analgesic supplies than
pharmacies in predominantly minority zip codes [60].
Similar results were reported in an earlier study of phar-
macies in the five boroughs of New York City [59]. While
pharmacies in both studies reported that “low demand”
was the main reason for not stocking such opioids, the
investigators found little evidence to support that expla-
nation as minor geographical variation in prevalence of
persistent pain disorders, if they exist, would not explain
the difference. Other reasons for having inadequate opioid
supplies had more credibility, including the fear of theft,
fraud, and illicit use, as well as regulations and additional
paperwork required by state and federal drug-
enforcement agencies [59,60].
Another study of pharmacists in New Mexico found that
pharmacists working for “chain pharmacies” were more
likely to express apprehension toward dispensing certain
types of opioids for pain treatment, frequently citing fear
of forgery as a reason for that apprehension [61].
Together, these findings point to the role of corporate
policies and varied regulatory requirements as contribut-
ing to the under-stocking of opioids [61,62]. Unfortu-
nately, these factors differentially impact populations with
selected social characteristics (e.g., racial and ethnic
minorities).
A4. Language Barriers Widen Pain Care Disparities
for Racial/Ethnic Groups with LEP
As pain is a subjective phenomenon, all pain management
is socially situated, generally using some form of commu-
nication as a vehicle for symptom presentation. About 24
million Americans have LEP [63], qualifying them for pro-
tections under Title VI of the Civil Rights Act of 1964. This
act prohibits discrimination in persons with LEP. While the
act requires all recipients of federal financial assistance to
provide meaningful language and interpretation access to
individuals with LEP, there is no uniform federal payment
policy for language interpretation/access. Hence, states
use heterogeneous methodologies for determining costs
and reimbursement [64]. Furthermore, Title VI requires
federal agencies to implement a system that provides
“meaningful language access,” including and beyond lan-
guage interpretation, but these language accommodation
programs are not consistently available or comprehensive
[65–67] and do not apply to private practitioners who do
not accept Medicare or Medicaid reimbursements. All of
these factors create the potential for disparities in pain
care for persons with LEP.
Persons with LEP, invariably racial and ethnic minorities,
report difficulty navigating the system and communicating
with providers even when access to services is not a
factor [68]. Like education and income, LEP is also a
social class variable in the United States that potentially
contributes to pain care disparities. Individuals with LEP
are likely to perform more hazardous work, report higher
rates of work-related injuries and consequent disabilities
[29], as well as worse health status and access to care
[69,70]. A study of claimants with nontraumatic low back
disorders by language preference found that claimants
who preferred the Spanish language received less back
surgery compared with those with English language pref-
erence. Furthermore, employers were more likely to
protest a compensable claim from Spanish- than English-
speaking individuals. Patients with LEP have also been
found to report less satisfaction with medical encounters,
have disproportionately lower rates of diagnostic testing,
and receive less explanation and follow-up from health
care providers when compared with English proficient
patients [71]. In a study conducted with a nationally rep-
resentative sample of African Americans, Hispanics, and
White people, low access to chronic pain care was inde-
pendently associated with Hispanic ethnicity, regardless of
financial concerns [72] (Table 1).
B. Policy and Advocacy: Summary of Issues
B1. Pain Undertreatment is a Public Health Problem
with Social and Fiscal Consequences and Should
Be Addressed in the Current Policy Debates
The direct and indirect cost of health disparities, between
2003 and 2006, was estimated to be $1.24 trillion [73],
compelling us to think of disparities not only from a moral
perspective but also with a public health lens. In contrast,
NIH research funding across “all” institutes that is devoted
Table 4 Indirect Affordable Care Act provisions
relevant to pain care disparities agenda [3]
Provision Section #
Train PCPs in cultural competence 5301
Develop and evaluate models of cultural
competence curricula
5307
Support collaborative research on topics
including cultural competence
5307
Require population surveys, Medicaid and
CHIP, no later than 2013, to collect and
report data on race, ethnicity, and primary
language
4302
Establish Patient-Centered Outcomes
Research Institute (PCORI) to examine
health disparities through comparative
effectiveness research
6301
Incentivize payments for reducing health care
disparities
1303
Standardize drug labeling, including risks and
benefits
3507
PCPs = primary care providers.
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to disparities research is about $2.9 billion [74,75]. Thus,
the cost of disparities, including those associated with
pain, far exceeds the resources made available to address
them. This makes a case for a paradigm shift toward
approaching pain disparities within a public health primary
and secondary preventative lens focusing on reducing the
incidence of injuries and medical conditions causing pain
and on early access to effective pain care for prevention of
persistent pain and related disability.
While the cost of racial and ethnic disparities related to
pain undertreatment remains unspecified, it is likely to
contribute significantly to the overall fiscal burden. Unre-
lieved pain afflicts more Americans than such chronic
Table 5 Advocacy and policy: Recommendations for change
# Issues/Perspectives Recommendations
B1 Pain undertreatment is a public
health problem with social and fiscal
consequences and should be
addressed as such in the current
policy debates.
a. Develop an alternative framework for understanding and
addressing disparities (e.g., disparity as a “medical error” within
the quality of care paradigm).
b. Set corresponding quality assurance standards for pain treatment
(e.g., through Centers for Medicare and Medicaid Services or
National Quality Forum).
c. Include measures of disparities as part of PPSG statewide pain
report cards.
B2 Broad legislative and regulatory
efforts are underway to address the
national prescription opioid misuse
epidemic. Heightened regulatory
fears may translate into systematic
bias and under-prescription of pain
medications for certain vulnerable
groups.
a. The issues of pain undertreatment and opioid diversion/misuse
have reached epidemic levels in the United States. Both
problems have real personal, social, and fiscal consequences.
Providers, legislators, and regulators must work together to
balance these concerns.
b. Anticipate and address systematic bias in under-prescription for
certain groups that can result from regulatory surveillance
programs (e.g., Prescription Monitoring Programs (PMP), and
Risk Evaluation and Mitigation Strategies [REMS], etc.).
c. Educational campaigns for stakeholders and providers, such as
“Look at the Data Campaigns,” to encourage data-driven decision
making.
d. Develop educational programs to focus not only on opioid risk
mitigation but also on principles of effective pain management
and the judicious use of opioids for pain treatment.
e. Educate legislators, regulators, and providers that an increase in
opioid prescription rate is not a necessary consequence of good
pain management.
B3 Pain advocacy groups strive to
address the issue of undertreatment
of pain, but an agenda to eliminate
pain treatment disparities continues
to be underemphasized.
a. Pain advocacy groups should unite on issues of common interest,
such as disparities in pain care.
b. A pain disparities agenda should be articulated in the missions of
leading pain advocacy organizations.
c. Innovative advocacy models are needed to aggressively engage
key stakeholders in discussing issues and generating solutions.
B4 Targeted educational campaigns and
public health “pain disparities”
marketing programs are missing from
pain advocacy campaigns.
a. Institute public health marketing campaigns for disparities similar
to “Ask me if I’ve washed my hands” and The Joint Commission’s
SPEAKUPTM [85].
B5 ACA has provisions that pertain
directly and indirectly to ameliorating
pain treatment disparities. The
challenge for the pain community is
how to leverage these opportunities.
a. Pain medicine professionals, pain disparities researchers and
patient advocacy groups must consider all opportunities provided
by the ACA and National Partnership for Action to End Health
Disparities [18] initiatives to ameliorate pain treatment disparities.
b. Focus attention in existing forums (e.g., American Pain Society’s
Pain Disparities Special Interest Group).
c. Need to encourage focus on pain treatment disparities in
Comparative Effectiveness Research.
ACA = Affordable Care Act; PPSG = Pain and Policy Studies Group.
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morbidities as heart disease, cancer, and diabetes com-
bined [76], making it the single most common reason for
which people seek medical care [4]. Chronic pain also
correlates with disability, poor quality of life, relational
problems, lost income/productivity, and higher health care
utilization (e.g., longer hospital stays, more emergency
room visits, and more unplanned clinic visits).
Studies have found that minority patients often experience
pain for many years before being seen by pain specialists
[27,77]. For instance, Green et al. found that minorities
receiving chronic pain care at a tertiary pain center believed
that they should have been seen in a pain clinic sooner.
Moreover, they reported frequent emergency room use for
chronic pain management in the years prior to their tertiary
care referral [54]. It is important to note that the latter study
and most existing studies pertain to patients who are
already in the system and fulfill referral criteria set by PCPs.
Hence, these data shed little light on patients who do not
have resources to access the system [77].
Counterintuitively, low income has been found to be an
independent predictor of higher direct cost related to pain
treatment [78]. Although reasons for this have not been
directly investigated, people in lower income brackets may
be less able to pay for preventative/early pain treatment,
rendering them more vulnerable to pain crises and more
costly treatments that require hospitalization [78]. Clearly,
the latter pattern reflects increased health care costs to
society when patients lack access and are not treated
effectively in a timely manner.
B2. Broad Legislative and Regulatory Efforts are
Underway to Address the National Prescription
Opioid Misuse Epidemic. These Heightened
Regulatory Fears May Translate into a Systematic
Bias and Under-Prescription of Pain Medications for
Certain Vulnerable Groups
In recent years, prescription drug abuse has claimed more
lives than illicit drugs in the United States. In 2007 alone,
there were over 38,000 drug-induced deaths, mostly
attributable to the unintentional overdose of prescription
pain medications [79]. The need for balanced pain control
and diversion policies is evident and is reflected in several
recent national strategic actions. On April 19, 2011, the
Obama administration announced a comprehensive plan
to address the national prescription drug abuse epidemic.
That plan mandates education of the medical community
regarding proper opioid prescribing practices [80]. In addi-
tion, regulatory efforts are underway to reduce the risk of
opioid misuse and diversion, including the prescriber edu-
cation component of the opioid risk evaluation and mitiga-
tion strategy (REMS) and expansion of state-based
prescription drug monitoring programs. Presently, 48
states and one territory either having an operative prescrip-
tion monitoring program (PMP) or have passed legislation
to implement such a program [81], although not all states
passing legislation enacting PMP have actually funded it.
In the context of pain treatment disparities, concerns arise
when heightened regulatory fears translate into a system-
atic bias that applies to certain groups more than others.
This systematic bias arises mainly due to stereotypes
about certain groups as having more prescription drug
abuse problem (e.g., selected racial minorities). A well-
developed body of research attests to such systematic
provider bias. As noted earlier, minorities, especially
Blacks and Hispanics, are less likely to receive opioids for
similar pain conditions and suffer more pain-related dis-
abilities. Indeed, most providers believe that the illicit drug
problem is significantly higher among minorities, although
data point otherwise [82]. Studies using nationally repre-
sentative data sets have found that White people are more
likely than Blacks to misuse “prescription opioids” [82].
Consistent with these findings, a recently released
Centers for Disease Control (CDC) report also found that
the highest rates of drug-induced deaths are among non-
Hispanic White people [79]. The rate of “any illicit” drug
use among persons aged 12 or older is also not signifi-
cantly different between Black and White people (9.6% vs
8.8%, respectively) and is much lower among Hispanics
and Asians (7.9% and 3.7%, respectively). Despite this
evidence, racial and ethnic minorities continue to receive
suboptimal pain treatment and are subject to more opioid
risk reduction strategies such as urine drug testing and
restricted early refills [83].
Thus, there is clear evidence of the need for broad advo-
cacy initiatives such as “Look at the Data Campaigns,”
especially targeted at providers to sensitize them to their
blind spots that contribute to inequitable pain care
(Box 2). In addition, it is important that such recent ini-
tiatives as the Office of National Drug Control policy to
address the national prescription drug abuse focus both
on risk mitigation and improved, culturally sensitive,
data-driven training of both PCPs and pain medicine
specialists [8].
B3. While Pain Advocacy Groups Strive to Address
Undertreatment of Pain, Pain Treatment Disparities
Continue to Be Underemphasized in Most Pain
Advocacy Programs
Recent legislative initiatives attest to the power of advo-
cacy in improving pain care, including the National Pain
Box 2 “Look At The Data” Campaign: What all
providers and stakeholders should know about race
ethnicity and prescription/illicit drug abuse
[79,82,155]
Black people and Hispanics are “less” likely than White
people to misuse “prescription” opioids.
The rate of “any illicit drug” use among persons aged
12 or older is “not” significantly different between Black
and White people and is much lower among Hispanics
and Asians.
The overall rates of drug-induced deaths are highest
among non-Hispanic White people.
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Care Policy Act of 2009 (S660). Such initiatives serve
to put the pain care agenda on the national scene. The
Act, in particular, was a culmination of actions under-
taken by several advocacy organizations. Several com-
ponents of this Act subsequently were included in
the Patient Protection and Affordable Care Act (in
Section 4305 of the Health Insurance Reform Legislation)
[3].
While pain advocacy organizations have served as cata-
lysts for addressing the undertreatment of pain, the issue
of disparities in pain care is not explicitly articulated in
the broader mission of most leading pain advocacy
organizations (Table 2). The lack of a united agenda
related to issues such as disparities in pain care under-
cuts work that is needed related to professional stan-
dards, provider education, and patient and system
outcomes. All advocacy groups must advocate for the
elimination of pain care disparities, improved access to
evidence-based treatments for all patients, as well as
unite against special interests groups that undermine
these goals.
There is also a need for innovative advocacy models
that aggressively engage key stakeholders in discussing
issues and generating solutions. For instance, the Center
for Practical Bioethics has taken a rather unconventional
approach to pain advocacy through a national campaign
to engage local “leaders.” Since the summer of 2010,
The Pain Action Initiative: A National Strategy (PAINS)
conducted five roundtable discussions with key stake-
holders in five major cities of the United States to gather
data on those living with, treating, legislating about,
and/or regulating pain care. Information from the five
roundtable discussions was synthesized into a report
that will serve as a roadmap for targeted advocacy and
educational initiatives [84]. This approach may serve
several purposes: to create awareness, to assess readi-
ness for change among individual leaders and orga-
nizations, to mobilize resources toward developing
ground-up action and advocacy plans, and to energize
stakeholders at the local level. More interestingly, pain
treatment disparities emerged as one of the issues in the
PAINS report, offering an opportunity for the pain dis-
parities community to engage in developing a national
strategy.
B4. Targeted Educational Campaigns and Public
Health “Pain Disparities Marketing Programs” Are
Missing from Pain Advocacy Campaigns
The treatment of pain requires both communication and
negotiation between patients and providers. Targeted
advocacy campaigns similar to “Ask me if I’ve washed
my hands” and The Joint Commission’s SPEAKUPTM
[85] can educate patients and the public in ways that
can bring about change in the culture of pain treatment.
For instance, a simple message campaign such as “Is
my pain well-managed?” may empower patients to
expect appropriate treatment and to hold providers
accountable for mismanaged pain. While such a cam-
paign may appear to run counter to national initiatives to
curb opioid prescription rates, however, the goal would
not be to increase the rate of opioid prescriptions, but to
encourage good pain management principles following
biopsychosocial model of pain care. Thus, to attain
optimal outcomes, integrated pain management tailored
to patient preferences may include the appropriate use
Table 6 The central role of primary care providers (PCPs) in patient-centered medical home: Implications
for pain care disparities
Section 3502. Health Teams and Patient-Centered Medical Home
A medical home is a mode of
care that includes:
• Personal physicians
• Whole person orientation
• Coordinated and integrated care
• Evidence-informed medicine and appropriate health information technology
• Expanded access to care
PCPs are required to: • Provide a care plan for each patient
• Provide access to health records
• Meet regularly with the care team to ensure integration of care
Health team and entities are
required to:
• Establish a contract with the PCPs
• Support patient-centered medical homes
• Collaborate with existing entities to coordinate disease prevention and chronic
condition management initiatives
• Develop and implement interdisciplinary care plans that integrate clinical and
community preventive services
• Provide 24-hour care management and support during transitions in care settings
• Serve as liaison to community prevention and treatment programs
• Include a variety of health care disciplines within the team
• Agree to provide services to individuals with chronic conditions
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of one or more of numerous types of treatment, includ-
ing physical therapies, behavioral strategies, other more
mechanism-specific medications (e.g., for neuropathic
pain disorders), and complementary and alternative
treatments. In addition, evaluation and management of
comorbidities, such as depression or anxiety, psycho-
logical factors such as catastrophizing, social factors
such as family or work stress, and occupational factors
such as ergonomics all may contribute to optimizing
outcomes [86].
Thus, it will be important to educate legislators and
regulators that an increase in opioid prescribing rates is
not a necessary consequence of good pain manage-
ment and, indeed, may indicate a lack of access to more
comprehensive and effective pain management. It
should also be evident that public education should go
hand in hand with provider education and training on
these principles of good pain management and the
reality of pain undertreatment among minorities and
underserved.
B5. The Patient Protection and ACA Has Provisions
that Pertain Directly and Indirectly to Ameliorating
Pain Treatment Disparities. The Challenge for the
Pain Community Is How to Shape as Well as
Leverage These Opportunities
The ACA has explicit provisions in Section 4305 that
directly pertain to reducing disparities in pain treatment
through support for disparities research and for training
providers in the delivery of culturally and linguistically
appropriate pain care services (Table 3). In addition, other
ACA provisions indirectly support the pain disparities
agenda through mandating uniformity in racial and ethnic
data collection, improving workforce diversity, emphasiz-
ing patient-centered outcomes research, and supporting
research on cultural competence (Table 4). This is indeed
an important step forward in situating pain disparities
within the larger plan for health care reform. The challenge
for the pain community is how to leverage these emerging
opportunities to implement the vision or retain this impor-
tant momentum (Table 5).
Table 7 Workforce-related factors: Recommendations for change
# Issues/Perspectives Recommendations
C1 Minorities are severely underrepresented in health
provider workforce in the United States.
a. Health Resources and Services Administration (HRSA),
specifically its Bureau of Health Professions, should
work with health professional schools (medicine,
nursing, pharmacy, dentistry, psychology, and social
work), public or private hospitals, and accrediting
organizations to implement innovative strategies to
recruit, mentor, and retain health professionals from
diverse racial, ethnic, and socioeconomic backgrounds.
C2 Primary care provider (PCPs), who manage the
majority of chronic pain in the United States, lack
training in managing complex pain patients.
a. Recommendation (C1-a) should include a specific focus
on primary care as PCPs are more likely to manage and
coordinate pain care than any other provider in the
health system.
b. Targeted education and training in pain treatment
disparities should be emphasized in both graduate
medical education (GME) and continuing medical
education (CME), as well as in licensure, accreditation,
and certification programs for medicine, nursing, and
allied health professions.
C3 PCP knowledge and training in pain management is
increasingly relevant in the context of emerging
models such as Medical Home that designates PCPs
with central responsibility for providing and
coordinating patients’ health care.
a. Federal agencies such as Centers for Medicare and
Medicaid Services, the United States Department of
Veterans Affairs, Department of Defense, and private
agencies such as the Joint Commission and National
Quality Forum should establish and advance standards
for adequate pain management as a quality of care
indicator and use it as a component of evaluating
patient outcomes.
C4 One in four actively practicing physicians in the
United States is an International Medical Graduate
(IMG). The pain practice needs of this large and
important element of the physician workforce has
been absent from scientific inquiry or policy
initiatives.
a. Targeted training (C2-b) in pain care disparities should
apply to all IMGs as they are more likely to work with
minorities, the underserved, and those in primary care
shortage areas.
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C. Workforce-Related Factors: Summary of Issues
C1. Minorities Are Severely Underrepresented in the
United States Health Provider Workforce
Diversity plays direct and indirect roles in improving mean-
ingful health care access among minorities and under-
served. Minority providers, including international medical
graduates, are more likely to serve minority and under-
served populations [87]. Minority providers also play a role
in improving language access among LEP patients and
may be more sensitive to individuals of various cultures
and backgrounds. While the precise role of cultural diver-
sity and mechanisms via which it impacts outcomes
remain under-investigated in the pain literature, some lit-
erature suggests that physicians of diverse backgrounds
may bring unique characteristics to the physician–patient
interaction. In a recent study, Heins et al. [88] investigated
the association between patient–provider characteristics
and reduction in pain intensity scores among patients
presenting to 20 EDs across the United States and
Canada. The investigators found that treatment by a phy-
sician of non-white race was the strongest predictor of
reduced pain intensity. More interestingly, non-white phy-
sicians (a group comprising of African Americans, Hispan-
ics, Asian Americans, and others) achieved better pain
control while prescribing opioids at lower rates than white
physicians. These results led the authors to conclude that
characteristics of the physician–patient interaction, rather
than specific pharmacological treatments, influenced the
outcomes [88].
Unfortunately, minorities are severely underrepresented
in health provider workforce in the United States. For
instance, only 3.5% of the physician workforce is Black
people/African American, and only 4.9% are Hispanics
[89]. Similar trends are noted in the nursing workforce:
only 16.8% of registered nurse workforce is from a
racial and ethnic minority group [90]. Of these, only 5.8%
are Black people/African American and only 3.6% are
Hispanics [90].
C2. PCPs, Who Manage the Majority of Chronic
Pain Patients in the United States, Lack Training in
Managing Complex Pain Patients
The majority of pain treatment in the United States occurs
in primary care settings [31,58]. Pain is generally under-
assessed in primary care [91], and minority patients, espe-
cially Black people, are at risk for pain under-assessment
and treatment, as well as the use of disproportionate risk
management strategies by PCPs [83]. Staton et al. inves-
tigated factors related to underestimation of chronic non-
cancer pain by physicians in 12 in primary care centers
[32]. PCPs were significantly more likely to underestimate
pain in Black people compared with all other ethnicities.
This evidence is unfortunate as primary care offers the
best opportunity for early identification of patients at risk of
developing chronic, persistent pain and long-term disabil-
ity [92]. Not surprisingly, models for clinical and cost-
effective pain treatment in primary care are currently
lacking [93]. Of course, such treatment is complicated by
the presence of physical and psychological comorbidities,
both of which have been identified as important correlates
of comorbid pain [94,95], disability [96], and increased
cost of pain care in primary care settings [93,97,98].
Moreover, such comorbidities disproportionately affect
minorities. PCPs may lack knowledge of specific pain
syndromes [99] and/or of risk management with opioids
[100–104]. Data from several studies reflect these issues:
73% of PCPs in a VA setting expressed moderate–strong
agreement that patients with chronic pain are a major
source of frustration and 38% reported significant levels of
dissatisfaction with their ability to provide optimal pain
relief [105]. Other studies have suggested that PCPs who
are less confident about using opioid analgesics are sig-
nificantly less likely to identify pain as a clinical priority and
are more likely to believe that patients with chronic pain
should see a specialist [106].
C3. PCP Knowledge and Training in Pain
Management Is Increasingly Relevant to Emerging
Models Such as the Medical Home, Where PCPs
Have Central Responsibility for Providing and
Coordinating Patients’ Health Care
Legislative initiatives to reform health care and various
demonstration projects [107–109] place strong emphasis
on improving primary care services and coordination by
implementing Patient-Centered “Medical Home” (PC-MH)
models. PC-MH models are based on the principles of
accessibility, continuity, and care coordination, which offer
an encouraging alternative to current gatekeeper models
of primary care. Unlike the gatekeeper model that rewards
less care, the medical home model rewards “quality” and
“patient-centeredness” while encouraging efficiency.
The core feature of a PC-MP is its central management by
PCPs, who facilitate, manage, and coordinate patient-
centered care across all levels, including referrals to and
care provided by specialists. By assigning PCP responsi-
bility across all aspects of patient care, the model encour-
ages more effective, equitable, and efficient health care
delivery [108]. Moreover, Section 3502 of ACA (Establish-
ing community health teams to support the patient-
centered medical home; Table 6) designates PCP
responsibility for “. . . all stages of life: acute care; chronic
care; preventive services; and end of life care” [3].
The development of the PC-MH model is promising for
pain care as the “intensive involvement of single physician”
has been found to be the single most important factor in
improving chronic pain outcomes [110]. While the model is
promising, it also raises some concerns, especially when
PCPs lack familiarity with and knowledge of pain syn-
dromes or opioid risk management. The models that
center on the role of PCPs [111], such as the stepped care
model that is now being implemented by Directive in the
Veterans Health Administration [112], necessitate, first
and foremost targeted training and education of PCPs in
pain care and pain treatment disparities [113,114] as well
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as improved training of pain medicine specialists in evalu-
ating and managing these complexities.
Thus, for the newer PC-MH model to be effective, targeted
PCP training and education in pain care is needed. As the
PC-MH model is incentivized to reward care coordination
and patient outcomes, it is also in the best interest of PCPs
to improve equity in pain management. Equity, of course,
involves sensitivity to treatment disparities and the appro-
priate use of referrals to improve outcomes across all
subgroups. While the Medical Home model has been
applied in many health care settings, its impact on improv-
ing pain care has not yet been realized or measured.
C4. One in Four Actively Practicing Physicians in
the United States Is an International Medical
Graduate. The Pain Practice Needs of This Large
and Important Element of Physician Workforce
Have Been Absent from Scientific Inquiry or
Policy Initiatives
International Medical Graduates (IMGs) are physicians
who have graduated from medical schools outside the
United States. Their practices account for one-quarter of
all visits to office-based physicians in the United States.
They are also more likely to work in primary care settings,
including primary care shortage areas outside of metro-
politan areas [87]. IMGs tend to work with poor and medi-
cally underserved populations [115] who are at higher risk
for developing persistent pain [116].
Unique barriers to practice exist for this significant work-
force [117]. In the specific setting of pain management,
barriers to analgesic availability and the use in IMG source
countries, coupled with low standards for pain manage-
ment, may contribute to a lack of foundational training with
acute and chronic pain management [117].
While IMGs in the United States represent 127 countries
[118], the majority are from developing countries. For
instance, India is the largest source country for the
United States IMGs, supplying 20% of the IMGs in the
United States. A report by the Human Rights Watch,
Unbearable Pain [119] based on interviews with different
patients, physicians, and regulators presented a con-
cerning picture of pain management across the Indian
Table 8 Provider level factors: Recommendations for change
# Issues/Perspectives Recommendations
D1 Education and training in promoting
equitable pain care does not match the
needs of providers across various types,
levels, and settings.
a. Consistent with recommendation C2-b, there is a need for
a roadmap for undergraduate, graduate, and postgraduate
educational models to match the training needs across
provider types and levels.
b. Targeted education and training in pain treatment
disparities should be emphasized in both graduate medical
education (GME) and continuing medical education (CME),
as well as in licensure, accreditation, and certification
programs for medicine, nursing, and allied health
professions.
c. The above programs should strategically target providers
who are more likely to manage chronic pain, minorities, and
the underserved (e.g., PCPs and IMGs).
D2 Effective models of cultural diversity training
must be developed, implemented, and
evaluated.
a. Successful models of cultural diversity training must make
training “feel relevant” to individual providers.
b. If research can demonstrate that the training leads to
improved patient outcomes, then the incentives under the
ACA may support the relevance to providers.
c. Training and continuing education programs should equip
health providers with tools to identify and address explicit
and implicit biases in practice.
D3 Conceptual models capable of explicating
factors that occasion disparities in pain
treatment and medical judgments are
lacking.
a. Research is needed urgently for developing and evaluating
models and best practices that can improve
patient–provider communication, shared-medical decisions,
and patient-centered pain care.
D4 While best practices and models are
needed, misguided models toward
improving patient provider interaction may
not serve to advance the goals of equitable
pain care.
a. An idea or best practice model calling for policy change
must meet scientific, pragmatic, and normative criteria. An
idea or model that falls short of fulfilling any of these
criteria should be questioned vigorously by the scientific
community.
ACA = Affordable Care Act.
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states investigated. Consistently, a survey of Pakistani
physicians from general medicine and surgery at teach-
ing hospitals found a serious lack of knowledge of
cancer pain management. For instance, when asked
about the oral analgesia of choice in terminal cancer
pain, 50% were not able to offer an answer, 20% iden-
tified NSAIDs as the oral analgesic of choice; only 13%
identified oral opioids of an agent of choice for terminal
cancer pain [120].
Macro-level factors in the source countries may
also contribute to a lack of experience with analgesic
pharmacotherapy among IMG physicians [117]. In 2007,
the population-adjusted amount of morphine available in
the United States was 76.73 mg/capita. This contrasts
with the developing world, where only 0.61 mg/per capita
was available for patients in India, 0.17 mg/capita in the
Philippines, 0.34 mg/capita in Mexico, and 0.03 mg/
capita in Pakistan [121]. Hence, many IMGs may have
prescribed an opioid analgesic only rarely, much less have
ordered patient-controlled analgesia for acute pain man-
agement or a sustained release preparation [117]. Unfor-
tunately, such inexperience can be compounded by
conditions in the United States, currently characterized by
a lack of education and training in pain management,
growing concerns about prescription drug abuse, fear of
drug-enforcement agencies, and a litigious culture.
Equally unfortunate, IMG-related issues in pain practice
have been unattended, both from a scientific and from a
policy perspective [117]. Indeed, existing credentialing
requirements do not assess for challenges presented by
the United States health care system that are unique to
IMGs (Table 7).
D. Provider Factors: Summary of Issues
D1. Provider Education in Promoting Equitable Pain
Care Does not Match the Needs of Providers
Across Various Types, Levels, and Settings
The debate surrounding cultural diversity training typically
focuses on changing the health professional curriculum
[122–125]. These models of education offer ways to trans-
form existing academic learning so that students are
better prepared to meet the challenges they face in reduc-
ing inequities in care. While curricular changes are much
needed, such change does not address the needs of
health professionals who are already in practice. Further-
more, such changes would not impact the training of
physicians, nurses, and other health professionals who
graduated from schools in other countries. Thus, post-
graduate educational models are needed to meet the
training needs of providers across levels and practice
settings. Targeted education and training is especially
important for strategic segments of health providers such
as PCPs and IMGs, for reasons discussed previously.
State licensing agencies (e.g., the Federation of State
Medical Boards) could take a leadership role in evaluating
models for postgraduate education on providing equitable
pain care. The best and most promising models could
then be disseminated throughout the membership.
The ACA has specific provisions focusing on developing
and evaluating models of cultural competence training
over the next five years. These provisions include training
PCPs in cultural competence, as well as loan repayment
programs that will give preference to culturally competent
individuals (see Box 3).
The specific training needs for international medical and
nursing graduates, who need transitional training to
operate effectively in the United States health care system,
should be evaluated. This likely will require partnering with
agencies such as the Educational Commission for Foreign
Medical Graduates and the Commission on Graduates
of Foreign Nursing Schools. These agencies establish
credential equivalence for foreign medical and nursing
graduates, respectively. Another partner could be the
Foundation for the Advancement of International Medical
Education and Research, which promotes excellence
in international health profession education through pro-
grammatic developments and research activities.
D2. Effective Models of Cultural Diversity Training
Must Be Developed, Implemented, and Evaluated
Most providers do not believe that cultural competence
training applies to them. Rather, they believe that their
treatment decisions are free from bias and/or stereotypes
(such as those associated with race/ethnicity). This discon-
nect between perception and reality is a likely consequence
of implicit (i.e., intuitive) processes that can influence clinical
judgments. These processes occur almost automatically,
so that they generally operate outside the range of con-
scious decision making [126]. Nonetheless, such pro-
cesses can bias clinical decisions. For instance, one study
revealed an implicit preference for favoring white patients
and an implicit stereotype for disfavoring black patients,
despite the fact that the participating physicians expressed
“no explicit preference” for treating white vs black patients
[127]. That study also demonstrated a direct relationship
between physicians’ pro-White implicit bias and their like-
lihood of offering more treatment to whites and less treat-
ment to Black people [127].
Efforts to address the effects of such implicit biases in
medical decision making have been largely educational in
Box 3 Provisions in Affordable Care Act relating to
cultural competence
Provision Section #
Training primary care providers in
cultural competence
5301
Developing and evaluating
models of cultural competence
curricula
5307
Supporting collaborative research
on topics including cultural
competence
5307
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nature. Much of that training has been directed at physi-
cians in training, and the results suggest that such training
programs have been reasonably successful in cultivating
sensitivity toward gender, racial and ethnic diversity, and
socioeconomic status, effectively reducing inequities in
care [128]. In fact, a follow-up study of the impact of a
medical education program in disparities demonstrated a
higher likelihood for participants to serve underrepre-
sented minorities; program participation was also an inde-
pendent predictor for future practice in disadvantaged
areas [129].
While educational interventions may be effective for phy-
sicians in training, interventions that can produce behavior
change in practicing physicians have been elusive. In part,
this may reflect current medical practice, particularly the
time urgency that often characterizes such practice.
Under conditions of time urgency, implicit biases (that
operate automatically) may be particularly likely to influ-
ence medical decisions [126,130]. Any efforts at enhanc-
ing cultural diversity among practicing providers must
include sensitivity to such time pressures, as well as other
ways to make training “feel relevant.” For example, rel-
evance would be enhanced if cultural competency training
were mandated by the Federation for State Medical
Boards. Similarly, if the practice of medicine shifts toward
the implementation of medical homes, there would be
incentives for providers to consider causal chains in ill
health, using a framework for social determinants that
considers differences in living environments [131]. Of
course, another benefit of a medical home would involve
access to multiple practitioners with coordination by a
PCP; such multidisciplinary approaches to care may miti-
gate the effects of implicit biases relative to single-
practitioner models. Finally, technology-based models
have been proposed that rely upon culturally and linguis-
tically appropriate decision-support systems to promote
patient-centered care [3].
D3. Conceptual Models Capable of Explicating
Factors that Occasion Disparities in Medical
Judgments are Lacking
The Schulman study [132], the IOM [16] report, and
many subsequent studies provide support for the con-
tribution of negative stereotypes to inequities in care.
Studies have also identified patient factors, such as less
active participation in medical decision making [133] and
negative expectations regarding the outcomes of care
[134,135], that may shape patient–provider interactions.
The IOM report also suggested that selected situational
factors (e.g., time urgency) were likely to provide fertile
ground for the above factors to positively influence care
[16]. Taken together, the factors suggest an organizing
role for a social judgment model, in which combinations
of patient, provider, and situational factors contribute to
disparate care.
There have been several attempts to organize the pain
literature around social psychological constructs related to
patient and provider factors that occasion inequitable
care. These models focus on shared-medical decision
making [136], social judgments [137], and facilitation of
patient communication with providers [138].
Frantsve and Kerns proposed that a shared-medical
decision-making (SMD) model be applied to the pro-
cesses involved in pain treatment [136]. The SMD
approach emphasizes the interactive give and take that
characterizes collaborative decisions, incorporating both
physician and patient preferences. The authors argue that
the SMD model is a particularly good fit for chronic pain
treatment, secondary to its subjective nature, long-term
features, and the common need to adjust treatment along
the time course.
A social judgment model also has been applied to the
disparities literature [137]. According to this model,
observer (provider) judgments are influenced by charac-
teristics of the observer, the target (patient), and the situ-
ation in which the judgment is made [139]. Obviously,
race/ethnicity describes a patient characteristic that is
potentially sufficient to influence judgments itself. More
commonly, patient characteristics interact with provider
stereotypes, beliefs, and attitudes to influence judgments.
While some of those beliefs and attitudes may be con-
scious and intentional, they often operate at less con-
scious (implicit) levels, consistent with a dual-process
model of decision making [126]. Evidence that such pro-
cesses operate broadly in clinical care is widespread,
ranging from EDs [35,47,51,140] to surgical specialties
[141]. Because such factors often influence judgments in
a nondeliberate manner, they are not readily subject to
direct change. Instead, they can only be minimized by
approaches to clinical care that promote individualized
rather than stereotypic care. Several studies, none involv-
ing pain treatment, have examined the role of cultural
competence and patient centeredness to facilitate such
care [142]. These studies demonstrated statistically
significant, but modest differences in assessment skills
for culturally competent medical students [143], and
increased patient satisfaction with care among minority
patients of physicians that demonstrate sensitivity to
issues related to cultural competence [144]. Unfortunately,
as this research does not speak to how to foster such
characteristics, efforts to develop training programs are
only now being studied [130].
Targeting the patient side of the patient–provider interac-
tion, there is some evidence that interventions aimed at
facilitating collaboration between patients and providers
can impact pain treatment outcomes positively [138]. This
study compared the relative effects of tailored communi-
cation training against traditional medical education in
patients being treated for cancer pain. Results indicated
that that tailored communication training was associated
with greater reductions in pain, but also that those reduc-
tions were particularly pronounced for minorities. There is
an urgent need for research to identify models and best
practices that can improve patient–provider communica-
tion, shared-medical decisions, and patient centeredness
in pain care.
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D4. While Best Practices and Models Are Needed,
Misguided Models Toward Improving Patient
Provider Interaction May Not Serve to Advance the
Goals of Equitable Pain Care
Any idea that calls for best practice and policy change
must meet scientific, pragmatic, and normative criteria. An
idea that falls short of fulfilling any of these criteria should
be questioned vigorously. Research on the role of patient–
provider race-concordance in improving health care and
service outcome is a case in point. In theory, unequal pain
treatment resulting from implicit bias should be attenuated
in a race-concordant patient–provider relationship, where
the relationship is expected to improve mutual trust and
communication. While there is some evidence supporting
this concept, the majority of the literature relates to non-
pain-related settings. The few pain studies that have
tested the role of patient–provider race-concordance have
Table 9 Research-related factors: Recommendations for change
# Issues/Perspectives Recommendations
E1 The incidence of pain
care disparities may
be actually higher
than documented.
a. Need for a federal infrastructure to conduct pain disparities research.
b. Existing national longitudinal health surveys (e.g., federally mandated population
surveys) should routinely include questions related to pain care access, utilization, and
outcomes.
c. Need to capture appropriate populations who are more likely to experience pain care
disparities, e.g., those receiving care in centers that serve predominantly minorities and
underserved.
d. Need for studies to quantify the actual cost of pain care disparities along the lines of
existing reports [73] to demonstrate the magnitude of the issue to mobilize needed
resources.
E2 The ability to track
disparities, monitor
efforts to reduce
them, and compare
findings across
studies has been
limited due to lack of
consistent data
collection on race
and ethnicity.
a. The issue of consistency in race/ethnicity data collection must be evaluated for two
overarching issues: what racial and ethnic categories should be employed in the
research and how race/ethnicity data are collected.
b. Need for public and private partnerships in promoting standardized reporting of race
and ethnicity data for which ACA can serve as a vehicle.
c. These existing classification schemes (self-report vs observer report) should be
examined in the light of the evidence of interactions among patient–provider and
system level factors in the genesis of pain care disparities.
E3 Research and
evidence-base is
lacking for best
practices for
improving pain care
among racial and
ethnic groups.
a. NIH Pain Consortium and National Institute on Minority Health and Health Disparities
(NIMHD) should play a key role in leading an effort with other Institutes and Centers at
NIH to improve research and funding for understanding and eliminating pain care
disparities.
b. Improve funding mechanisms to increase research training in pain care disparities, with
specific support for pre- and post-doctoral trainees and junior investigators.
c. Federal agencies such as NIH, Centers for Disease Control, Agency for Healthcare
Research and Quality, as well as private agencies should increase support for research
training in pain disparities research within their existing programs of research on pain.
d. As disparities are pervasive across pain treatment settings, a subanalysis of pain
disparities should be seen as integrated and inclusive component of all pain research
studies rather than as a separate domain of scientific inquiry.
e. Improve evidence-base on disparities:
i. Use tailored strategies to recruit and retain minority individuals in studies and clinical
trials.
ii. Routinely oversample minorities in pain research.
iii. Improve consistency in race/ethnicity data collection across studies.
iv. Homogenize measures to study outcomes (see IMMPACT, PROMIS initiatives).
v. Use analytical methods that allow for nuanced and deeper understanding of
pathways, interactions, and outcomes.
f. Leverage on emerging federal initiatives (e.g., PCORI) to examine relations between
pain disparities and outcomes through comparative effectiveness research (see ACA
section 6301) [3].
ACA = Affordable Care Act; NIH = National Institutes of Health; PCORI = Patient-Centered Outcomes Research Institute.
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lacked adequate statistical power and sufficient patient–
provider samples to address the question with confi-
dence. In addition, this literature lacks attention to IMGs,
who comprise 25% of actively practicing physicians in the
United States. The idea of race-concordance overlooks
the vast heterogeneity that exists within racial and ethnic
categories. For instance, Asian racial categories range
from Japanese to Pakistanis [145]. The 2010 Census
found 9 million people who identified themselves as multi-
racial or belonging to more than one race [146] (up from
6.8 million in 2000) [147] complicating any approach
to the study of the effects of patient–provider racial
concordance.
More importantly, the model does not satisfy normative
criteria for two important reasons: 1) attempts to promote
patient–provider race concordance can potentially create
a racial divide in the health care sector [145] and 2) such
a notion can mistakenly impart a sense of “exoneration”
among nonminority providers. That is, providers in the
latter group might conclude that only certain types of
patient–provider relations can be expected to produce
optimal pain management outcomes. Thus, while best
practices and models are urgently needed, misguided
models toward improving patient–provider interaction may
detract from the goal of advancing equitable pain care at
the expense of consuming valuable resources [148]
(Table 8).
E. Research-Related Factors: Summary of Issues
E1. The Incidence and Magnitude of Pain
Care Disparities May Be Actually Higher
Than Documented
Several scientific issues directly relate to the under-
assessment of pain care disparities and the consequent
lack of efforts to reduce them. First, the documented
incidence of pain care disparities may be lower than the
actual incidence because most studies on pain disparities
derive from academic medical centers rather than centers
that predominantly treat minorities and underserved popu-
lations. In addition, the disparities that are documented
exist despite access to care (i.e., they pertain to minorities
that are already in the health care system) [77]. Minorities
that are not in the health care system (or not in a part of
the system likely to generate research) are underrepre-
sented in this research. Thus, most studies of pain care
disparities cannot portray disparities that occur due to
lack of health care access. While costs of pain disparities
have not been quantified, access issues are likely to
contribute substantially to yearly costs. For instance,
people in lower income brackets (a disproportionate
number of whom are racial and ethnic minorities) may be
less able to pay for preventative or early stage pain treat-
ments, rendering them more vulnerable to pain crises and
more costly to the system [78]. Longitudinal surveys of
community-dwelling individuals, especially those who
receive care in centers that predominantly serve minority
and underserved patients, are needed to paint an
accurate picture of the magnitude of access-related dis-
parities and relevant outcomes. Furthermore, systematic
studies are needed to quantify the actual cost of pain care
disparities along the lines of existing reports [73] to dem-
onstrate the import of the issue and mobilize needed
resources.
E2. The Ability to Track Disparities, Monitor Efforts
to Reduce Them, and Compare Findings Across
Studies Has Been Limited due to a Lack of
Consistent Data Collection on Race and Ethnicity
The majority of pain disparities research is based on ret-
rospective analyses of data collected for clinical pur-
poses [19,20]. A recent meta-analysis of analgesic
treatment for pain in the United States found consider-
able heterogeneity in the specific operationalization of
racial and ethnic subgroups [19,20] (see Meghani et al.
[20], in this issue). Even those studies that have specific
aims related to pain care disparities lack consistency in
race/ethnicity data collection, making it difficult to
compare findings across studies. Cross-study variability
derives from the use of inconsistent racial and ethnic
categories as well as heterogeneous methods for col-
lecting and documenting these data. The ACA has
several provisions aimed at improving data collection
and reporting with the sole intention of tracking and tar-
geting health disparities. Specifically, ACA Section 4302
mandates population surveys and federally funded pro-
grams to collect and report data on race, ethnicity, and
primary language, as well as the requirement to track
trends in health care disparities.
While legislative efforts are aimed at achieving uniformity
in collection of racial and ethnic categories, they do not
homogenize the manner in which these data are gath-
ered. Self-report of race and ethnicity is considered
better than observer-recordings. However, both methods
have important limitations. For instance, misclassification
is a major problem with observer-assigned race/ethnicity,
whereas self-reporting within the six broad Office of
Management and Budget categories for race/ethnicity
limits ways in which individuals may self-identify. For
instance, the NIH identifies people of Northern Africa as
Whites [149] (e.g., Egyptians), which may be in conflict
with how these individuals see themselves. Furthermore,
researchers have justified the use of observer-assigned
race/ethnicity, arguing that disparities are occasioned by
how one is perceived as opposed to how one self-
identifies. Thus, the issue of consistency in race/ethnicity
data collection must be evaluated for two overarching
issues: 1) what racial and ethnic categories are
employed and operationalized in the research studies,
and 2) how race/ethnicity data are collected. Further-
more, the broad efforts under ACA of homogenizing
race/ethnicity data collection may fall short if corre-
sponding efforts are not implemented in private sectors.
Nonetheless, we can hope that provisions within ACA
that are geared toward improving disparities research
may serve to promote standardized reporting among
public and private sectors.
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E3. Research and Evidence Base for Best Practices
for Improving Pain Care Among Racial and Ethnic
Groups Is Lacking
Advances in closing the gap in pain treatment and out-
comes among vulnerable populations is hampered by
existing gaps in knowledge pertaining to environmental,
biological, behavioral, and psychological mechanisms and
their interactions. The majority of pain disparities research
focuses on documenting evidence of disparities and less
frequently on identification of sources of disparities.
Acutely missing from this body of literature are best prac-
tices or evidence-based models to ameliorate these
known disparities. Moving forward, the challenge for pain
disparities researchers is to increase evidence-base and
convert this understanding to meaningful interventions to
reduce and eventually eliminate disparities.
As discussed earlier, the NIH funding for pain research
in general and pain care disparities in particular has
remained inadequate (Box 1). Federal agencies such as
NIH, Centers for Disease Control, Agency for Healthcare
Research and Quality as well as private agencies should
increase support for research training in pain disparities
research within their existing programs of research on
pain. More specifically, the NIH Pain Consortium and
National Institute on Minority Health and Health Disparities
should play a key role in leading an effort with other
Institutes and Centers at NIH to improve research and
funding for understanding and eliminating pain care dis-
parities as well as to increase research training in pain care
disparities, with specific support for pre- and post-
doctoral trainees and junior investigators.
Recent federal initiatives make it an opportune time to
investigate innovative interventions to improve pain treat-
ment and outcomes. For instance, comparative effective-
ness research offers a new paradigm to study health
outcomes in the context of intervention. Similarly, ACA
Section 6301 creates a Patient-Centered Outcomes
Research Institute (PCORI) that will carry out comparative
effectiveness research and examine differences in health
service outcomes among racial and ethnic groups [3].
However, to identify best models for practice change and to
improve outcomes among diverse patients, it is important
to bring consistency in race/ethnicity data collection, to use
tailored strategies to recruit and retain minority individuals,
and also to homogenize measures to study outcomes.
There are heterogeneous measures of pain intensity, pain
quality, pain interference, pain relief, quality of analgesia,
and impression of change with treatment, all of which make
it difficult to understand findings and outcomes across
studies. The NIH Roadmap Initiative, PROMIS, is a step in
that direction [150]. The goal of the initiative is to enable
clinicians and researchers to have access to efficient, valid,
and responsive indicators of patient-reported health status
and outcomes. PROMIS provides access to item-banks
[151]; from these banks, items can be selected to make
customized scales or can be used as tailored/adapted
instruments, the length of which can be determined by
computer technologies. Measures undergo rigorous quali-
tative and psychometric evaluations [152,153] and can be
used in clinical, observational, comparative effectiveness
trials, and health services research. Recent psychometric
evaluations of some PROMIS banks, including pain inter-
ference and pain behavior, have demonstrated good psy-
chometric properties [152,153]. Other ongoing initiatives
such as the Initiative on Methods, Measurement, and Pain
Assessment in Clinical Trials (IMMPACT) aim to improve
design, execution, and interpretation of clinical trials of
pain. The goal of these initiatives is to test measures over
time with various clinical and demographic groups so that
accumulated findings not only have a common metric and
range, but a shared meaning and understanding across
populations [151]. These emerging paradigms should be
exploited to generate an evidence-base for improving pain
care among minority and underserved patients (Table 9).
Conclusions
Inequities in pain care remain an important and often
neglected health policy concern. There is no question that
pain treatment disparities matter in many significant ways;
the most important are the tremendous burdens placed
on patients, health systems, and society when the most
effective pain care is not accessible, affordable, and deliv-
ered to those in need. Until the prevailing issues of
inequitable health care are realized and confronted
through focused and systematic strategies for education,
research, and health care reform, it is unlikely that
progress will occur in reducing and ultimately eliminating
pain disparities. In this report, we acknowledge the per-
vasive nature of pain treatment disparities and elucidate
numerous factors that contribute to disparate health care
for patients experiencing pain.
Contemporary thinking about pain disparities requires a
new paradigm with an organized etiological model that
drives opportunities for change. Here, we propose such
a paradigm to re-conceptualize the obvious and not so
obvious disparities in pain care, and to align strategic
and corrective actions that have a high likelihood for
success. By partitioning the problem of pain disparities
into domains of structural/system, policy and advocacy,
workforce, health care provider, and research, it is pos-
sible to grasp the magnitude of disparities and their
impact on the health of those experiencing pain. A blue-
print is constructed to consolidate issues contributing to
disparities. Each domain is carefully and thoughtfully
analyzed, and supporting data from both scientific and
expert consensus perspectives substantiate the perva-
siveness of the problem. We offer a pedagogical and
practical roadmap for examining root causes for pain
disparities and navigating action plans capable of bring-
ing about necessary changes. Action plans include
multi-tier, methodological, and evidence-based solutions
that transcend the traditional ways of conceptualizing
disparities. Summaries at the end of each domain
section prioritize the most salient points related to the
issues at large.
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Recently, the IOM report, Relieving Pain in America: A
Blueprint for Transforming Prevention, Care, Education,
and Research [5], has been released pursuant to ACA’s
charge to the Department of Health and Human Services
to examine pain as a public health problem. IOM’s broader
recommendations for improving pain care for all Ameri-
cans will directly and indirectly improve the care of vulner-
able populations. While our report deals specifically and
exclusively with pain care disparities, the IOM report
addresses issue of disparities as part of its population
strategy (see findings and recommendations 2-2, and 3-2)
[5]. The IOM report gives due importance to the issue of
pain care disparities submitting it as part of its immediate
and short-term goals, i.e., goals that should be initiated
now and completed before the end of 2012 (see IOM
recommendation 3-2) [5].
The thorny issue of pain care disparities and its sheer
magnitude requires immediate and sustained efforts to
broach the issue. The fundamental flaws in our structural
systems preclude the ability of legislation and policies,
alone, to mitigate deep-rooted practices that perpetuate
disparities. Unless drastic changes occur in how dispari-
ties are approached, we will remain in the status quo of
talking about pain disparities rather than acting to
resolve them. Even with the best of intent, the lack of
education, evidence-based practice models, and
accountability in care makes it difficult to penetrate
sectors of health care system to promote equitable care.
Any research, practice, and policy initiatives resulting
from IOM recommendations should have a focus on pain
care disparities as one of the sub aims. The NIH Pain
Consortium and National Institutes on Minority Health
and Health Disparities can play a key role in leading an
effort with other Institutes and Centers at NIH to improve
research and funding for understanding and eliminating
pain care disparities as well as to prepare a pipeline of
scientists for sustained impact. While there is no one
answer to abolishing the unnecessary pain and suffering
caused by unequal access and treatment, continued
and sustained progress can be made on multiple fronts
by uniting under a new and all inclusive paradigm for
addressing pain-related disparities.
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